<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>TEDE Communidade:</title>
    <link>https://tedebc.ufma.br/jspui/handle/tede/544</link>
    <description />
    <pubDate>Mon, 10 Aug 2026 21:59:33 GMT</pubDate>
    <dc:date>2026-08-10T21:59:33Z</dc:date>
    <image>
      <title>TEDE Communidade:</title>
      <url>http://tede2.ufma.br:8080/jspui/retrieve/1241/ciencas.jpg</url>
      <link>https://tedebc.ufma.br/jspui/handle/tede/544</link>
    </image>
    <item>
      <title>Avaliação do efeito analgésico e anti inflamatório do ambroxol em modelo experimental de osteoartrite em rato</title>
      <link>https://tedebc.ufma.br/jspui/handle/tede/7133</link>
      <description>Título: Avaliação do efeito analgésico e anti inflamatório do ambroxol em modelo experimental de osteoartrite em rato
Autor: MESQUITA, Micheline Joana Tenório Albuquerque Madruga
Primeiro orientador: GARCIA, João Batista Santos
Abstract: Ambroxol is a mucolytic agent widely used in the treatment of respiratory diseases; however, &#xD;
Ambroxol is a mucolytic agent widely used in the treatment of respiratory diseases. However, &#xD;
evidence from the literature has demonstrated its anti-inflammatory, analgesic, and &#xD;
immunomodulatory properties, suggesting its potential for drug repurposing. In this context, &#xD;
this thesis integrated a systematic review and an experimental study to investigate the &#xD;
mechanisms of action and therapeutic effects of ambroxol in experimental models of non&#xD;
pulmonary diseases, with an emphasis on osteoarthritis (OA). Initially, a systematic review was &#xD;
conducted, registered in the Open Science Framework (OSF), following the PICO strategy and &#xD;
PRISMA guidelines, with searches performed in the PubMed/MEDLINE, Embase, and Scopus &#xD;
databases. Of the 353 studies identified, eight met the eligibility criteria. The review &#xD;
demonstrated that ambroxol exerts anti-inflammatory, antioxidant, and antinociceptive effects &#xD;
in different non-pulmonary experimental models by reducing pro-inflammatory cytokines &#xD;
(TNF-α, IL-1β, and IL-6), increasing the activity of antioxidant enzymes (superoxide &#xD;
dismutase, catalase, and glutathione), decreasing oxidative stress, improving histopathological &#xD;
changes, and attenuating pain through mechanisms related, among others, to the blockade of &#xD;
voltage-gated sodium channels, thereby reinforcing its potential for drug repurposing. &#xD;
Subsequently, an experimental study was conducted to evaluate the antinociceptive and anti&#xD;
inflammatory effects of ambroxol in an experimental model of osteoarthritis. Adult male Wistar &#xD;
rats underwent OA induction on day zero (D0) by intra-articular injection of monosodium &#xD;
iodoacetate (MIA) and were allocated into the following groups: Healthy, Negative Control &#xD;
(CTRL−), Meloxicam (2 mg/kg), and Ambroxol (10, 50, and 100 mg/kg). Treatments were &#xD;
administered orally by gavage once daily for 28 days. Behavioral assessments included the &#xD;
Rotarod test, Gait Analysis, Weight Bearing test, Von Frey test, and Rat Grimace Scale, in &#xD;
addition to radiographic and histopathological evaluations and quantification of pro- and anti&#xD;
inflammatory cytokines (IL-1β, IL-6, and IL-10). Ambroxol treatment significantly improved &#xD;
nociceptive parameters and motor function, while reducing radiographic and histopathological &#xD;
scores, showing performance comparable to meloxicam in several outcomes. Marked &#xD;
reductions in IL-1β and IL-6 levels were observed, whereas IL-10 levels were lower in the &#xD;
ambroxol-treated groups, suggesting an earlier resolution of the inflammatory response. Taken &#xD;
together, the findings from the systematic review and the experimental study demonstrate that &#xD;
ambroxol exhibits consistent anti-inflammatory, antioxidant, and antinociceptive properties, in &#xD;
addition to attenuating structural joint damage associated with osteoarthritis. These findings &#xD;
reinforce the potential of ambroxol as a candidate for drug repurposing in osteoarthritis. Further &#xD;
studies are required to better elucidate its mechanisms of action, establish the optimal dosage &#xD;
regimen and treatment duration, and support the translation of these findings into clinical &#xD;
studies.
Instituição: Universidade Federal do Maranhão
Tipo do documento: Tese</description>
      <pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tedebc.ufma.br/jspui/handle/tede/7133</guid>
      <dc:date>2026-07-08T00:00:00Z</dc:date>
    </item>
    <item>
      <title>PACIENTES RENAIS CRÔNICOS ATENDIDOS NA FARMÁCIA ESTADUAL DE MEDICAMENTOS ESPECIALIZADOS NO MUNÍCIPIO DE SÃO LUÍS, MARANHÃO: Perfil clínico-epidemiológico, estudo etnofarmacológico e estratégias para Farmacovigilância</title>
      <link>https://tedebc.ufma.br/jspui/handle/tede/7118</link>
      <description>Título: PACIENTES RENAIS CRÔNICOS ATENDIDOS NA FARMÁCIA ESTADUAL DE MEDICAMENTOS ESPECIALIZADOS NO MUNÍCIPIO DE SÃO LUÍS, MARANHÃO: Perfil clínico-epidemiológico, estudo etnofarmacológico e estratégias para Farmacovigilância
Autor: MUNIZ, Raoni Sousa
Primeiro orientador: AMARAL, Flavia Maria Mendonça do
Abstract: Chronic Kidney Disease (CKD) is a syndrome characterized by progressive changes&#xD;
in renal structure and function, presenting high morbidity and mortality and a significant&#xD;
socioeconomic impact. Due to its complex clinical progression, the disease requires&#xD;
continuous care and prolonged use of medications to ensure access to therapies that&#xD;
control the progression of the pathology and reduce complications, making the&#xD;
Specialized Component of Pharmaceutical Assistance essential in Brazil. However,&#xD;
the traditional use of medicinal plants and barriers to accessing health services&#xD;
encourage self-medication with herbal preparations, which can represent serious risks&#xD;
to patients with CKD due to possible adverse events. Given this scenario, this study&#xD;
aimed to describe the epidemiological profile and pattern of use of plants for medicinal&#xD;
purposes among patients with CKD, evaluating potential risks of drug interactions with&#xD;
specialized treatment and proposing measures to minimize dangers in this population.&#xD;
The methodology consisted of an observational, cross-sectional, and analytical study&#xD;
with 280 patients registered in the Horus system and assisted by the State Pharmacy&#xD;
of Specialized Medicines in São Luís, Maranhão, Brazil. Data were collected through&#xD;
interviews using a structured questionnaire, and medical records were used to confirm&#xD;
the disease; multivariate logistic regression analysis was applied to identify factors&#xD;
associated with the use of plants for medicinal purposes. The results revealed a&#xD;
sample with a slight male predominance (50.71%) and a higher concentration in the&#xD;
51-60 age group (22.86%). The socioeconomic profile showed low educational&#xD;
attainment, with 70.00% of patients having completed high school, and marked&#xD;
financial vulnerability, with 93.57% living on less than two minimum wages. Regarding&#xD;
the diagnosis of CKD, 51.79% discovered the disease in routine examinations,&#xD;
although 18.21% had a family history, mainly first-degree relatives (34%). The practice&#xD;
of polypharmacy is evident, with 78.57% of respondents using additional medications,&#xD;
primarily for the control of metabolic disorders and hypertension. Approximately 15%&#xD;
of patients use plants for medicinal purposes, with the most frequent species being:&#xD;
lemon balm (Lippia alba (Mill.) N.E. Br., 5.36%), lemongrass (Cymbopogon citratus&#xD;
(DC.) Stapf, 3.57%), chamomile (Matricaria recutita L., 2.14%), boldo (Plectranthus&#xD;
barbatus Andrews, 1.79%), and mango leaf (Mangifera indica L, 1.07%). Thus, the&#xD;
clinical risk is aggravated by polypharmacy and/or the use of species with nephrotoxic&#xD;
potential. It is concluded that the implementation of pharmacovigilance actions and the&#xD;
qualification of healthcare professionals are imperative measures to mitigate risks and&#xD;
promote the rational use of therapeutic resources in this population.
Instituição: Universidade Federal do Maranhão
Tipo do documento: Dissertação</description>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tedebc.ufma.br/jspui/handle/tede/7118</guid>
      <dc:date>2026-03-27T00:00:00Z</dc:date>
    </item>
    <item>
      <title>EFEITOS DO AMBIENTE ISOLADO, CONFINADO, EXTREMO SOBRE OS ESTADOS DE HUMOR NA ESTAÇÃO ANTÁRTICA COMANDANTE FERRAZ</title>
      <link>https://tedebc.ufma.br/jspui/handle/tede/7093</link>
      <description>Título: EFEITOS DO AMBIENTE ISOLADO, CONFINADO, EXTREMO SOBRE OS ESTADOS DE HUMOR NA ESTAÇÃO ANTÁRTICA COMANDANTE FERRAZ
Autor: GOMES, Jayne Pimenta
Primeiro orientador: MENDES, Thiago Teixeira
Abstract: Introduction: Antarctica represents one of the most challenging scenarios for human presence,&#xD;
characterized as an isolated, confined, and extreme (ICE) environment, in which factors such&#xD;
as geographic isolation, restricted mobility, environmental monotony, and intense seasonal&#xD;
variations act simultaneously. In this context, mood emerges as a variable sensitive to the&#xD;
interaction between psychobiological and environmental factors, being widely used as an&#xD;
indicator of adaptation in extreme conditions. Objective: To analyze the effects of the ICE&#xD;
environment on the mood states of military personnel at the Comandante Ferraz Antarctic&#xD;
Station (EACF). Methodology: Sixteen military personnel participated in the study, monitored&#xD;
over 11 months in 2020, with six data collection phases (January to November). The Brunel&#xD;
Mood Scale (BRUMS) questionnaire was applied, and anthropometric measurements were&#xD;
taken. The data were analyzed using IBM SPSS Statistics 23.0, adopting descriptive statistics&#xD;
(mean and standard deviation or median and interquartile range, according to the data&#xD;
distribution). Normality was verified by the Shapiro–Wilk test, and differences between periods&#xD;
were assessed by the Friedman test, with a significance level of p ≤ 0.05. Results: There were&#xD;
no statistically significant differences in mood dimensions verified by the Friedman, TMD, and&#xD;
Effect Size indices over the analyzed period (p &gt; 0.05), suggesting a pattern of positive mood&#xD;
in the ICE environment. Conclusion: The findings suggest that exposure to the isolated,&#xD;
confined, and extreme (ICE) environment of Antarctica did not promote statistically significant&#xD;
changes in mood dimensions over time, indicating stability of positive mood during the&#xD;
analyzed period.
Instituição: Universidade Federal do Maranhão
Tipo do documento: Dissertação</description>
      <pubDate>Thu, 30 Apr 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tedebc.ufma.br/jspui/handle/tede/7093</guid>
      <dc:date>2026-04-30T00:00:00Z</dc:date>
    </item>
    <item>
      <title>AÇÃO ANTI-INFLAMATÓRIA E ANALGÉSICA DO ÓLEO DE ANDIROBA (Carapa guianensis Aubl.) EM MODELO EXPERIMENTAL DE OSTEOARTRITE</title>
      <link>https://tedebc.ufma.br/jspui/handle/tede/7077</link>
      <description>Título: AÇÃO ANTI-INFLAMATÓRIA E ANALGÉSICA DO ÓLEO DE ANDIROBA (Carapa guianensis Aubl.) EM MODELO EXPERIMENTAL DE OSTEOARTRITE
Autor: FIGUEIREDO, Isaias Moreira de
Primeiro orientador: CARVALHO, Rafael Cardoso
Abstract: Osteoarthritis is one of the most limiting chronic diseases, often resulting in pain and&#xD;
functional impairment of affected joints. In this context, medicinal plants represent a&#xD;
therapeutic alternative due to their well-documented traditional use as antiinflammatory and analgesic agents, such as Carapa guianensis Aubl. (andiroba). The&#xD;
aim of this study was to investigate the pharmacological effects of C. guianensis seed&#xD;
oil in an experimental model of osteoarthritis in rats. The oil was analyzed by Gas&#xD;
Chromatography coupled with Mass Spectrometry (GC-MS) to identify its major&#xD;
components and was administered orally, by gavage, at doses of 250, 500, and 1000&#xD;
mg/kg. Osteoarthritis was induced in the right knee of the animals using sodium&#xD;
monoiodoacetate (MIA). The animals were subjected to behavioral tests, including&#xD;
forced locomotion (Rotarod test), spontaneous pain assessment (Von Frey test), and&#xD;
weight distribution (Weight Bearing test), to evaluate the antinociceptive effect of the&#xD;
oil. In addition, radiological examinations and histological analyses of the knee joint&#xD;
were performed. The major compounds identified in the andiroba oil by GC-MS were&#xD;
palmitic acid, oleic acid, linoleic acid, and stearic acid. The oil exhibited antiinflammatory, antinociceptive, and chondroprotective effects in the experimental&#xD;
model. Behavioral tests demonstrated that higher doses improved locomotion and the&#xD;
use of the affected limb. Radiological and histological analyses confirmed preservation&#xD;
of joint structure, reduction of subchondral bone sclerosis, and decreased presence of&#xD;
marginal osteophytes, particularly at the highest treatment dose. Differences in&#xD;
treatment response between sexes were also observed. Thus, C. guianensis&#xD;
(andiroba) oil represents a promising bioproduct for the development of new&#xD;
therapeutic approaches for osteoarthritis.
Instituição: Universidade Federal do Maranhão
Tipo do documento: Dissertação</description>
      <pubDate>Wed, 29 Apr 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tedebc.ufma.br/jspui/handle/tede/7077</guid>
      <dc:date>2026-04-29T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

